Last checked at 1 Feb 2021 13:44
Monday broker round-up
(Sharecast News) - Polymetal International: Berenberg reiterates buy with a target price of 2,310p.
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades617
HIK
Live RNS
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions
HIK
Media
Hikma Pharmaceuticals Information
Share Price Information for Hikma Pharmaceuticals (HIK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,820.00
Bid:
1,820.00
Ask:
1,822.00
Change:
2.00 (0.11%)
Spread:
2.00 (0.11%)
Open:
1,825.00
High:
1,832.00
Low:
1,813.00
Prev. Close:
1,818.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.26 Jan 2021 08:28
TOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt And Tunisia
TOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt And Tunisia
Read more12 Jan 2021 10:13
Vectura Forecasts 2020 Earnings To Top Board Expectations
Vectura Forecasts 2020 Earnings To Top Board Expectations
Read more18 Dec 2020 17:08
LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal
LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal
Read more18 Dec 2020 12:08
LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound
LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound
Read more18 Dec 2020 10:45
UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura
UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura
Read more18 Dec 2020 08:12
Hikma rallies as it launches generic version of Glaxo asthma treatment
(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.
Read more17 Dec 2020 18:10
Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus
Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus
Read more2 Dec 2020 13:11
Wednesday broker round-up
(Sharecast News) - Royal Dutch Shell A: JP Morgan upgrades to overweight with a target price of 1,700p.
Read more24 Nov 2020 13:33
Tuesday broker round-up
(Sharecast News) - Glencore: Jefferies upgrades to buy with a target price of 250p.
Read more10 Nov 2020 13:17
Tuesday broker round-up
(Sharecast News) - On the Beach: Citigroup downgrades to neutral with a target price of 370p.
Read more10 Nov 2020 09:44
UK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next
UK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next
Read more5 Nov 2020 10:44
TOP NEWS: Hikma Lifts Annual Guidance; Launches Generic Drug In US
TOP NEWS: Hikma Lifts Annual Guidance; Launches Generic Drug In US
Read more5 Nov 2020 09:24
LONDON MARKET OPEN: Pound Keeps Lid On FTSE 100 As BoE Boosts Support
LONDON MARKET OPEN: Pound Keeps Lid On FTSE 100 As BoE Boosts Support
Read more5 Nov 2020 09:15
Hikma raises FY guidance for generics unit following positive H1 momentum
(Sharecast News) - Pharmaceutical company Hikma said on Thursday that the group as a whole was "performing well" and had maintained the positive momentum seen in the first half, leading it to reiterate guidance for one unit and raise it on another.
Read more